ASPCF - Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q3 2020 Results - Earnings Call Transcript
Acerus Pharmaceuticals Corporation (ASPCF) Q3 2020 Results Earnings Conference Call November 03, 2020, 10:00 AM ET Company Participants Bob Motz - CFO Ed Gudaitis - President and CEO Gavin Damstra - Senior Vice President, US Commercial Chris Sorli - Chief Medical Officer Gavin Damstra - Senior Vice President, International Commercial Phil Savard - Vice President and General Counsel Aura Balboa - Director of Finance. Conference Call Participants Presentation Operator Good morning, ladies and gentlemen, and welcome to the Third Quarter 2020 Conference Call for Acerus Pharmaceuticals Corporation. At this time, all participants are in listen-only mode. A brief question-and-answer session will follow this discussion. [Operator Instructions] As a reminder, this conference is being recorded. It will be available for replay, through November 10, 2020 by dialing 905-694-9451 or 1800-408-3053 using the access code 4330175#. I would like now to turn the call over to Mr. Bob Motz, Chief Financial Officer
For further details see:
Acerus Pharmaceuticals Corporation (ASPCF) CEO Ed Gudaitis on Q3 2020 Results - Earnings Call Transcript